Casandra
Casandra Test Code QD50521Version 1 (DRAFT)
Performing Lab
Ziprasidone, Serum/Plasma
Clinical Use
Order TestUse
Therapeutic drug monitoring for ziprasidone to optimize drug therapy and assess patient adherence.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
Mass Spectrometry
Biomarkers
Ziprasidone
AnalyteZiprasidone • Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
Result Turnaround Time
4-9 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Serum
Volume
1 mL
Minimum Volume
0.4 mL
Container
Red top tube (no additive); Lavender top tube (EDTA); Pink top (EDTA)
Collection Instructions
Collect serum: red top; plasma: lavender or pink top tube; promptly centrifuge and separate into plastic screw capped vial.
Storage Instructions
Refrigerated
Causes for Rejection
Polymer gel separation tube (SST or PST)
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 30 days |
| Frozen | 12 month(s) |
Related Tests
Other tests from different labs that may be relevant
Ziprasidone, Serum or Plasma
Labcorp
Ziprasidone Quantitation, Serum or Plasma
ARUP Laboratories
Ziprasidone (Geodone, Zeldox)
Mayo Clinic Lab
Paliperidone (as 9‑Hydroxyrisperidone), Serum or Plasma
Labcorp
Quetiapine, Serum or Plasma
Labcorp
Mesoridazine, Serum or Plasma
Labcorp
Thioridazine and Mesoridazine, Serum or Plasma
Labcorp
Aripiprazole, Serum or Plasma
Labcorp
Olanzapine, Serum or Plasma
Labcorp
Aripiprazole and Metabolite, Serum or Plasma
ARUP Laboratories